CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-18 | Nabulsi Azmi Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2024-01-18 | Curran Terrie President and Chief Executive | Grant or award · Stock Option (Right to Buy) | +475,000 | 475,000 | ||
| 2023-11-20 | Henderson Molly CFO and CBO | Sale | −2,127 | $7.24 | $15K | 103,061 |
| 2023-11-08 | Parikh Asit Director | Purchase | +2,500 | $7.80 | $20K | 55,000 |
| 2023-11-07 | Parikh Asit Director | Purchase | +4,000 | $7.76 | $31K | 52,500 |
| 2023-11-06 | Parikh Asit Director | Purchase | +1,000 | $8.04 | $8K | 48,500 |
| 2023-11-01 | Henderson Molly CFO and CBO | Grant or award | +22,500 | 117,680 | ||
| 2023-11-01 | Henderson Molly CFO and CBO | Sale | −811 | $7.80 | $6K | 116,869 |
| 2023-11-01 | Henderson Molly CFO and CBO | Sale | −11,681 | $8.95 | $105K | 105,188 |
| 2023-11-01 | Nabulsi Azmi Chief Operating Officer | Grant or award | +32,500 | 242,067 | ||
| 2023-11-01 | Curran Terrie President and Chief Executive | Grant or award | +37,500 | 427,171 | ||
| 2023-07-14 | Henderson Molly CFO and CBO | Grant or award | +25,000 | 95,180 | ||
| 2023-07-14 | Henderson Molly CFO and CBO | Grant or award | +25,000 | $1.00 | $25K | 95,180 |
| 2023-07-14 | Curran Terrie President and Chief Executive | Grant or award | +200,000 | 389,671 | ||
| 2023-07-14 | Curran Terrie President and Chief Executive | Returned to the company · Stock Option | −175,000 | 0 | ||
| 2023-07-14 | Curran Terrie President and Chief Executive | Returned to the company · Stock Option | −225,000 | 0 | ||
| 2023-07-14 | Nabulsi Azmi Chief Operating Officer | Grant or award | +110,000 | 209,567 | ||
| 2023-07-14 | Nabulsi Azmi Chief Operating Officer | Returned to the company · Stock Option | −70,000 | 0 | ||
| 2023-07-14 | Nabulsi Azmi Chief Operating Officer | Returned to the company · Stock Option | −150,000 | 0 | ||
| 2023-06-02 | Parikh Asit Director | Grant or award | +15,000 | $7.40 | $111K | 47,500 |
Page 7 of 19 · 379 trades